Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Checkpoint Capital L.P. (CIK 1977548) reported $389.8M across 6 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: RYTM ($131.7M, 33.79%), ARGX ($121.8M, 31.25%), RVMD ($76.9M, 19.72%), CYTK ($40.5M, 10.38%), IRON ($17.6M, 4.51%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | RYTM | RHYTHM PHARMACEUTICALS INC | $131.7M | 33.79% | 1.2M | Trimmed |
| 2 | ARGX | ARGENX SE | $121.8M | 31.25% | 131,283 | Trimmed |
| 3 | RVMD | REVOLUTION MEDICINES INC | $76.9M | 19.72% | 410,353 | Added |
| 4 | CYTK | CYTOKINETICS INC | $40.5M | 10.38% | 475,000 | Added |
| 5 | IRON | DISC MEDICINE INC | $17.6M | 4.51% | 240,125 | Trimmed |
| 6 | TRVI | TREVI THERAPEUTICS INC | $1.4M | 0.36% | 75,000 | Added |
| 7 | CRNX | CRINETICS PHARMACEUTICALS IN | $0 | 0.00% | 0 | Exited |
| 8 | SEPN | SEPTERNA INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-06-30